Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Muennerstadt

3 clinical trials in Muennerstadt, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Muennerstadt at a glance
3
clinical trials
  • Recruiting now0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Muennerstadt

Open in trial search

Pulmonary fibrosis

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ADMILPARANT
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Idiopathic pulmonary fibrosis

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ADMILPARANT
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Pulmonary fibrosis

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil
  • Sponsor:United Therapeutics Corp.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Muennerstadt

What the registry says about research in the country

01 Muennerstadt
Respiratory Tract Diseases
Clinical research in Muennerstadt is centered on respiratory tract diseases, with a strong focus on chronic lung conditions that affect breathing and lung function. The studies are exploring ways to improve treatment outcomes for patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. Testing new therapies for fibrotic lung disease Evaluating improvements in forced vital capacity over time Comparing active treatment approaches with placebo These trials aim to better understand whether emerging treatments can slow disease progression and support lung function in people living with persistent pulmonary scarring.
Neoplasms
A second major research area is neoplasms, particularly non-small-cell lung cancer. The trial activity reflects interest in advancing cancer care through studies that compare treatment options and examine their effectiveness in adults with lung tumors. Studying treatment effectiveness in advanced lung cancer Comparing investigational therapy with established cancer care Assessing safety and immune response in non-small-cell lung cancer This work supports efforts to refine cancer treatment strategies and improve outcomes for patients facing difficult-to-treat lung malignancies.
Fibrotic Lung Disease Research
Several recruiting studies in Muennerstadt are focused on the broader field of fibrotic lung disease, where researchers are looking for better ways to manage ongoing scarring in the lungs. The main goal is to test whether new medicines can preserve lung function and ease disease burden. Investigating therapies for idiopathic pulmonary fibrosis Exploring treatment options for progressive pulmonary fibrosis Measuring changes in breathing capacity as a key outcome These studies may help clarify how new approaches perform in real patients and whether they offer meaningful benefits beyond current care.
Lung Cancer Clinical Research
The city also hosts research aimed at improving care for lung cancer, with particular attention to adults who have not previously received treatment for metastatic disease. The studies are designed to evaluate whether newer cancer therapies can offer better control of the illness. Comparing emerging therapy with Keytruda Studying efficacy and safety in untreated metastatic disease Supporting development of more effective oncology treatments This line of research is important for identifying options that may extend benefit while maintaining tolerability for patients with advanced cancer.
Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.